Real-World Effectiveness and Satisfaction with Risankizumab for the Treatment of Psoriatic Arthritis in Biologic-Naïve Patients: A Population Survey in the United States and Europe.

Walsh JA, Saffore CD, Ye X, Patel M, Biljan A, Vora J, Truman I, Edwards M, Milligan G, Ostor A

Open source

DOI
10.1007/s40744-025-00801-6
Published
2025 Dec
Container
Rheumatology and therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40744-025-00801-6,
  title = {Real-World Effectiveness and Satisfaction with Risankizumab for the Treatment of Psoriatic Arthritis in Biologic-Naïve Patients: A Population Survey in the United States and Europe.},
  author = {Walsh JA and Saffore CD and Ye X and Patel M and Biljan A and Vora J and Truman I and Edwards M and Milligan G and Ostor A},
  year = {2025},
  journal = {Rheumatology and therapy},
  doi = {10.1007/s40744-025-00801-6},
  url = {https://doi.org/10.1007/s40744-025-00801-6}
}

RIS

TY  - JOUR
TI  - Real-World Effectiveness and Satisfaction with Risankizumab for the Treatment of Psoriatic Arthritis in Biologic-Naïve Patients: A Population Survey in the United States and Europe.
AU  - Walsh JA
AU  - Saffore CD
AU  - Ye X
AU  - Patel M
AU  - Biljan A
AU  - Vora J
AU  - Truman I
AU  - Edwards M
AU  - Milligan G
AU  - Ostor A
PY  - 2025
JO  - Rheumatology and therapy
DO  - 10.1007/s40744-025-00801-6
UR  - https://doi.org/10.1007/s40744-025-00801-6
ER  - 

APA

JA, W., CD, S., X, Y., M, P., A, B., J, V., I, T., M, E., G, M., & A, O. (2025). Real-World Effectiveness and Satisfaction with Risankizumab for the Treatment of Psoriatic Arthritis in Biologic-Naïve Patients: A Population Survey in the United States and Europe.. Rheumatology and therapy. https://doi.org/10.1007/s40744-025-00801-6

Source records